Skip to content

Clinical trials

Atherosclerosis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atherosclerosis Country / region: Japan Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20041
20071
20086
20094
20103
20112
20124
20151
20171
20182
20203
20214
20225
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Active, not recruiting7
Recruiting7
Unknown status6
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen4
Boston Scientific Corporation4
Eli Lilly and Company4
GlaxoSmithKline4
Kurume University4
AstraZeneca3
Novartis Pharmaceuticals3
University of Shizuoka3
CSL Behring2
NewAmsterdam Pharma2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atherosclerosis49
Cardiovascular Diseases11
Dyslipidemias8
Coronary Artery Disease6
Acute Coronary Syndrome5
Hyperlipidemias5
Coronary Disease4
Diabetes Mellitus, Type 24
Hypercholesterolemia4
Heart Diseases3

Trials

Showing 26 to 49 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.